Nombre del producto:Propanedioic acid, 2-(4-bromophenyl)-, 1,3-dimethyl ester

IUPAC Name:1,3-dimethyl 2-(4-bromophenyl)propanedioate

CAS:149506-35-4
Fórmula molecular:C11H11BrO4
Pureza:95%+
Número de catálogo:CM427980
Peso molecular:287.11

Unidad de embalaje Stock disponible Precio($) Cantidad
CM427980-1g in stock ƃƃƃ
CM427980-5g in stock ƥȐƃ
CM427980-25g in stock ŵƿƛ

Sólo para uso en I+D..

Formulario de consulta

   refresh    

Detalles del producto

Núm. De CAS :149506-35-4
Fórmula molecular:C11H11BrO4
Punto de fusión:-
Código de sonrisas:COC(=O)C(C(=O)OC)C1=CC=C(Br)C=C1
Densidad:
Número de catálogo:CM427980
Peso molecular:287.11
Punto de ebullición:
Nº Mdl:MFCD06204131
Almacenamiento:

Column Infos

Aprocitentan
New Phase 3 data with aprocitentan for patients with resistant hypertension has been presented at the American Society of Nephrology Kidney Week 2023.
Aprocitentan is an investigational, novel, oral, dual endothelin receptor antagonist (ERA), which potently inhibits the binding of ET-1 to ETA and ETB receptors. Aprocitentan has a low potential for drug-drug interaction and a mechanism of action that is ideally suited for the pathophysiology of resistant hypertension.
A new drug application (NDA) for aprocitentan was accepted for review by the US FDA.